Helmholtz Gemeinschaft


Senescence apoptosis and therapy - cutting the lifelines of cancer

Item Type:Review
Title:Senescence apoptosis and therapy - cutting the lifelines of cancer
Creators Name:Schmitt, C.A.
Abstract:Apoptosis and senescence are cellular failsafe programmes that counteract excessive mitogenic signalling from activated oncogenes. Cancellation of apoptosis or senescence is therefore a prerequisite for tumour formation, and the ability of the cancer cell to disrupt these processes can be considered its 'lifeline'. Ironically, the efficacy of anticancer agents also depends on the activation of apoptosis or an acutely inducible form of cellular senescence. Understanding how the 'lifelines' of the cancer cell interfere with treatment sensitivity is of crucial importance for developing safer and more effective treatment strategies.
Keywords:Apoptosis, Cell Aging, Neoplasms, Neoplastic Cell Transformation, Oncogenes
Source:Nature Reviews Cancer
Page Range:286-295
Date:April 2003
Official Publication:https://doi.org/10.1038/nrc1044
PubMed:View item in PubMed

Repository Staff Only: item control page

Open Access
MDC Library